Subscribe today - find out more
Why you should consider BusinessDesk

Notification of Issue of Securities

SECISSUE
Wed, Sep 15 2021 02:57 pm

15 September 2021
Issue of ordinary shares
This notice is given under NZX Listing Rule 3.13.1 and relates to the issue of ordinary shares in Fisher & Paykel Healthcare Corporation Limited (“FPH”) under the Fisher & Paykel Healthcare 2003 Share Option Plan.
This notice is given in reliance on a waiver from NZX Listing Rule 3.13.1 granted by NZX on 6 August 2019 that allows FPH, subject to certain conditions, to disclose the issue of FPH shares under FPH’s employee share purchase schemes within 10 business days of issue.
Section 1: issuer information
Name of issuer Fisher & Paykel Healthcare Corporation Limited
NZX ticker code FPH
Class of Financial Product Ordinary shares
ISIN NZFAPE0001S2
Section 2: capital change details
Number of issuances to which this notice relates Three
Number issued (1) 114,961
(2) 28,824
(3) 82,068
Total issued: 225,853 shares
Nominal value (if any) Not applicable
Issue price (1) NZD0.00
(2) NZD14.91
(3) NZD11.81 (2,614 shares); NZD14.91 (44,121 shares); NZD0.00 (35,333 shares)
Nature of the payment Not applicable
Amount paid up (if not in full) In full
Percentage of total class of Financial Products issued (1) 0.01994%
(2) 0.00500%
(3) 0.01423%
For an issue of Convertible Financial Products or Options, the principal terms of Conversion Not applicable
Reason for issue (1) Vesting of 114,961 ESRs under the Employee Share Rights Plan (established 2018) and issue of 114,961 ordinary shares.
(2) Cancellation of 58,547 options and issue of 28,824 ordinary shares.
(3) Cancellation of 75,407 options and issue of 44,121 ordinary shares; cancellation of 4,093 options and issue of 2,614 ordinary shares; exercise of 35,333 PSRs under the Performance Share Rights Plan and issue of 35,333 ordinary shares.
All cancellations are under the FPH Share Option Plan Cancellation Facility
Total number of Financial Products of the Class after the issue (excluding Treasury Stock) and the total number of Financial Products of the Class held as Treasury Stock after the issue. (1) Total number (excluding Treasury Stock): 576,613,694.
Treasury stock: 137,282
(2) Total number (excluding Treasury Stock): 576,642,518.
Treasury stock: 137,282
(3) Total number (excluding Treasury Stock): 576,724,586.
Treasury stock: 137,282
Total number of ordinary shares on issue as at the date of this notice after the issues disclosed in this notice (excluding Treasury Stock): 576,724,586.
Treasury stock as at the date of this notice: 137,282.
Total number of ordinary shares on issue as at the date of this notice after the issues disclosed in this notice (including Treasury Stock): 576,861,868.
In the case of an acquisition of shares, whether those shares are to be held as treasury stock Not applicable
Specific authority for the issue Directors’ resolution, Listing Rule 4.6
Terms or details of the issue The ordinary shares issued rank pari passu with the existing ordinary shares
Date of issue (1) 13 September 2021
(2) 14 September 2021
(3) 15 September 2021
Section 3: authority for this announcement
Name of person authorised to make this announcement Marcus Driller
Contact phone number +64 9 574 0110
Contact email address marcus.driller@fphcare.co.nz
Date of release via MAP 15 September 2021

Announcement PDF

Markets News

Markets
The next carbon auction: predicting the unpredictable
Ian Llewellyn | Tue, 30 Nov 2021

The fourth auction will offer up 4.75 million New Zealand units with the current spot price trading near $65.

Markets
Omicron ordeal knocks NZ index 200 points
Dan Brunskill | Mon, 29 Nov 2021

The worst of the damage was staved off as the index's largest stock Fisher & Paykel Healthcare climbed 1.3%. 

Markets
Me Today gone tomorrow without cash top-up
Dan Brunskill | Mon, 29 Nov 2021

The health and beauty brand needs more cash – and it's getting it, about $6 million, to offset lower-than-expected income from its honey buy.

Infrastructure
Radius Care's first-half profit fell on rising employee costs
Staff reporters | Mon, 29 Nov 2021

Radius' employee costs rose 10.2% in the latest six months while its revenue rose 8.4%.

News in Brief
SkyCity gets covenant waiver, adds $50m facility
Staff reporters | Mon, 29 Nov 2021

The casino and hotel group has negotiated debt covenant waiver from its lenders and some headroom to help it navigate through its Auckland reopening.

Property
Oceania lifts first-half net profit 22.2%
Staff reporters | Mon, 29 Nov 2021

Oceania sold 57 new units and resold another 45 in the latest six months.

Hospitality
No vax, no room policy stuck in grey area
Brent Melville | Mon, 29 Nov 2021

The distinction between accommodation and food and beverage under vaccination mandates means hotel workers aren't being classed as high risk.

Property
Flickering Torchlight fund puts heat on Pyne Gould
Paul McBeth | Mon, 29 Nov 2021

Pyne Gould is still trying to work out what to do with its Torchlight assets when the fund expires next week. 

Markets market close
Nu-covid sends shares tumbling
Dan Brunskill | Fri, 26 Nov 2021

Investors are worried the new variant could mean a reintroduction of travel restrictions and lockdowns. 

Markets
Blackwell Global fined $40k for multimillion-dollar mistake
Dan Brunskill | Fri, 26 Nov 2021

The fine pales in comparison to the millions of dollars that were likely lost by retail investors caught up in the bubble. 

Markets
Uncertainty the only certainty for F&P Healthcare
Dan Brunskill | Fri, 26 Nov 2021

Fisher & Paykel Healthcare is still expecting revenue to fall at some stage, but analysts think the business will continue to prosper after the pandemic. 

Retail
NZ retailers embrace Black Friday: will shoppers?
Jenny Ruth | Fri, 26 Nov 2021

Relevance be damned, New Zealand's retailers have been quick to seize the sales opportunity. 

News in Brief market close
F&P Healthcare props up NZX50
Dan Brunskilll | Thu, 25 Nov 2021

The outlook for the company remains foggy, with not even senior management able to predict when the inevitable sales slowdown will occur.

Markets
Pacific Edge keeps throwing cash at US push
Staff reporters | Thu, 25 Nov 2021

Pacific Edge ramped up at its US laboratory but losses continue to mount as the diagnostics firm pushes for US growth.

Markets
Almost $1 billion: F&P defies market chatter
Staff reporters | Thu, 25 Nov 2021

Analysts from two of New Zealand’s largest brokers predicted a revenue decline between 7% and 9% for the half year as covid-related sales normalised.

Finance
Westpac's governance shortcomings laid bare
Jenny Ruth | Thu, 25 Nov 2021

RBNZ's stance on Westpac NZ vindicated as new report finds known issues ignored for years by the bank's board.

Technology
Demand drives 43% revenue boost for Rakon
Henry Burrell | Thu, 25 Nov 2021

Global chip shortage and 5G equipment remain key for the company to meet earnings guidance. 

Markets
Serko’s secret acquisition could save 18-months' work
Dan Brunskill | Thu, 25 Nov 2021

The travel booking company has set aside $21m for an acquisition it is currently negotiating with another global travel company. 

Markets market close
Stock market rallies as RBNZ eases rates higher
Dan Brunskill | Wed, 24 Nov 2021

Some interest rate sensitive utility stocks were having a strong day having been sold off earlier in the week.

Primary Sector
A2 Milk hit by second class action
Rebecca Howard | Wed, 24 Nov 2021

Shine Lawyers says 'bitter' investors have a right to recover their losses. 

Listed Companies
Tower shares rally as capital returns keep coming
Paul McBeth | Wed, 24 Nov 2021

Investors welcomed the prospect of a share buyback at a premium.

Markets
Serko to raise $85m as losses widen
Dan Brunskill | Wed, 24 Nov 2021

The travel booking software company's total operating revenue climbed 81% to $9.2m in the half year ended September.

Markets
Vista's Movio CEO and cofounder steps down
Staff reporters | Wed, 24 Nov 2021

Movio cofounder Will Palmer wants to flex 'his entrepreneurial muscles'. 

Infrastructure
'Heightened risk' at Fletcher's until review is complete – Jarden
Brent Melville | Wed, 24 Nov 2021

The impending market study into the $8 billion building materials sector is unlikely to lead to any rational change to the industry and has left its rating for Fletcher Building at neutral.